Sulfasalazine for the treatment of ankylosing spondylitis: relic or niche medication?
Ward, Michael M
Sulfasalazine for the treatment of ankylosing spondylitis: relic or niche medication? [electronic resource] - Arthritis and rheumatism Jun 2011 - 1472-4 p. digital
Publication Type: Comment; Editorial; Research Support, N.I.H., Intramural
1529-0131
10.1002/art.30225 doi
Antirheumatic Agents--therapeutic use
Etanercept
Humans
Immunoglobulin G--therapeutic use
Randomized Controlled Trials as Topic
Receptors, Tumor Necrosis Factor--therapeutic use
Spondylitis, Ankylosing--drug therapy
Sulfasalazine--therapeutic use
Sulfasalazine for the treatment of ankylosing spondylitis: relic or niche medication? [electronic resource] - Arthritis and rheumatism Jun 2011 - 1472-4 p. digital
Publication Type: Comment; Editorial; Research Support, N.I.H., Intramural
1529-0131
10.1002/art.30225 doi
Antirheumatic Agents--therapeutic use
Etanercept
Humans
Immunoglobulin G--therapeutic use
Randomized Controlled Trials as Topic
Receptors, Tumor Necrosis Factor--therapeutic use
Spondylitis, Ankylosing--drug therapy
Sulfasalazine--therapeutic use